Yirong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yirong Wang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Binbin Guo
Department of Genetics, School of Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou, China
65 shared publications - Fanrong Li
Department of Genetics, Medical College of Soochow University, Suzhou, Jiangsu, China
65 shared publications - Jiachun Lu
School of public health, Guangzhou medical university, Guangzhou, China
65 shared publications - Jian Zheng
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China and Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China
65 shared publications - Jieqiong Deng
Department of Genetics, Medical College of Soochow University, Suzhou, Jiangsu, China
65 shared publications - Jieyu Wang
Department of Genetics, Medical College of Soochow University, Suzhou, Jiangsu, China
65 shared publications
Latest Publications
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Related information to figure 2, figure 3, and figure 5
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Related information to figure 2, figure 3, and figure 5
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Primary clinical and histological characteristics of 67 study patients
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Primary clinical and histological characteristics of 67 study patients
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
The genomic position of the predicted ORFs of the six lncRNAs
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
The genomic position of the predicted ORFs of the six lncRNAs
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Sequences of LINC00887 and ACLY-BP cDNA
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Sequences of LINC00887 and ACLY-BP cDNA
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Materials and Methods from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Supplementary Materials and Methods
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials and Methods from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Supplementary Materials and Methods
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Sequences of shRNAs and siRNAs used in this study
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Sequences of shRNAs and siRNAs used in this study
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Related information to figure 6
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation
Related information to figure 6